Literature DB >> 25611699

Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells.

Lulu Farhana1, Marcia I Dawson, Joseph A Fontana.   

Abstract

Aberrant regulation of microRNA expression in pancreatic cancers has been shown to play an important role in its inherent poor prognosis and malignant potential. MicroRNAs have also been shown to inhibit translation of genes by targeting the 3'-untranslated region (3-UTR) of mRNAs resulting in the inhibition of translation and often destruction of the mRNA. In the present study we investigated the role of the microRNA miR-202 in the apoptotic pathways of pancreatic cancer cells. The adamantyl-related molecule, 3-Cl-AHPC down-regulated expression of miR-202 and miR-578 resulting in the increased expression of mRNA and protein expression of their target genes, Max dimerization protein 1 (Mxd1/Mad1) and the Sin3A associated protein 18 (SAP18). Overexpression of pre-miR-202 led to diminished levels of Mxd1 and blocked the 3-Cl-AHPC-mediated increase in Mxd1 mRNA expression. The addition of the microRNA inhibitor 2'-O-methylated miR-202 enhanced the 3-Cl-AHPC-mediated increase of Mxd1 mRNA levels as well as 3-CI-AHPC-mediated apoptosis. We found increased Mxd1 bound to the Sin3A repressor protein complex through its increased binding with HDAC-2 and subsequently enhanced transcriptional repression in cells as evidenced by increased HDAC activity. Mxd1 also repressed human telomerase reverse transcriptase (hTERT) mRNA expression through its increased binding to the hTERT promoter site and resulted in decreased telomerase activity in cells. Our results demonstrate that down regulation of miR-202 increased the expression of its target Mxd1, followed by Mxd1 recruitment to the Sin3A repressor complex and through its dimerization with Max, and increased repression of Myc-Max target proteins.

Entities:  

Keywords:  3-Cl-AHPC, (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid; ARR, Adamantly-substituted retinoid related; HDCA2, histone deacetylase 2; Mxd1, Max dimerization protein 1; Mxd1/Mad1; SAP18; SAP18, Sin3A associated protein 18; Sin3A; c-Myc; hTERT; hTERT, human telomerase reverse transcriptase; miR-202; miR-578; pancreatic cancer

Mesh:

Substances:

Year:  2015        PMID: 25611699      PMCID: PMC4623045          DOI: 10.4161/15384047.2014.987070

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  46 in total

Review 1.  The peptidomimetic, 1-adamantyl-substituted, and flex-het classes of retinoid-derived molecules: structure-activity relationships and retinoid receptor-independent anticancer activities.

Authors:  Marcia I Dawson; Joseph A Fontana
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

2.  Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1. Repression of Fas-induced caspase-8 activation.

Authors:  S Gehring; S Rottmann; A R Menkel; J Mertsching; A Krippner-Heidenreich; B Lüscher
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 3.  Conditional transgenic models define how MYC initiates and maintains tumorigenesis.

Authors:  Constadina Arvanitis; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2006-07-21       Impact factor: 15.707

4.  Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation.

Authors:  Lulu Farhana; Marcia I Dawson; Joseph A Fontana
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

Review 5.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

Review 7.  Sin3: master scaffold and transcriptional corepressor.

Authors:  Adrienne Grzenda; Gwen Lomberk; Jin-San Zhang; Raul Urrutia
Journal:  Biochim Biophys Acta       Date:  2009-06-06

8.  miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.

Authors:  Yi Zhang; Dayong Zheng; Yan Xiong; Chengbiao Xue; Gen Chen; Bibo Yan; Qifa Ye
Journal:  FEBS Lett       Date:  2014-04-03       Impact factor: 4.124

9.  Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer.

Authors:  Yu Zhao; Chenglong Li; Ming Wang; Liping Su; Ying Qu; Jianfang Li; Beiqin Yu; Min Yan; Yingyan Yu; Bingya Liu; Zhenggang Zhu
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

10.  MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression.

Authors:  Pedro M Costa; Maria C Pedroso de Lima
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-30
View more
  19 in total

1.  Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.

Authors:  Matteo Giulietti; Giulia Occhipinti; Giovanni Principato; Francesco Piva
Journal:  Cell Oncol (Dordr)       Date:  2016-05-30       Impact factor: 6.730

2.  MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2.

Authors:  Feng Yan Yu; Yun Tu; Ying Deng; Cancan Guo; Jue Ning; Yuzhen Zhu; Xiaohua Lv; Hua Ye
Journal:  Cancer Biol Ther       Date:  2016-09-29       Impact factor: 4.742

3.  miR-202 acts as a potential tumor suppressor in breast cancer.

Authors:  Shanshan Gao; Chunfang Cao; Qingfu Dai; Jian Chen; Jiancheng Tu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

Review 4.  The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression.

Authors:  Zuhair Hawa; Inamul Haque; Arnab Ghosh; Snigdha Banerjee; LaCoiya Harris; Sushanta K Banerjee
Journal:  Int J Mol Sci       Date:  2016-05-26       Impact factor: 5.923

5.  MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39.

Authors:  Rende Guo; Jianhua Gu; Zhibin Zhang; Yi Wang; Chuan Gu
Journal:  Biomed Res Int       Date:  2017-01-19       Impact factor: 3.411

6.  miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1.

Authors:  Yuexiong Yi; Huirong Li; Qiongying Lv; Kejia Wu; Wenfen Zhang; Juan Zhang; Dingjun Zhu; Qing Liu; Wei Zhang
Journal:  Oncotarget       Date:  2016-11-01

7.  Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.

Authors:  Bruna Cristine de Almeida; Natalia Garcia; Giovana Maffazioli; Laura Gonzalez dos Anjos; Edmund Chada Baracat; Katia Candido Carvalho
Journal:  Int J Mol Sci       Date:  2017-12-25       Impact factor: 5.923

Review 8.  Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.

Authors:  Muhammad Khairul Ramlee; Jing Wang; Wei Xun Toh; Shang Li
Journal:  Genes (Basel)       Date:  2016-08-18       Impact factor: 4.096

9.  Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2.

Authors:  Yingjun Deng; Xin Li; Jinxin Feng; Xiangliang Zhang
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

Review 10.  MicroRNA Regulation of Telomerase Reverse Transcriptase (TERT): Micro Machines Pull Strings of Papier-Mâché Puppets.

Authors:  Ammad Ahmad Farooqi; Qaisar Mansoor; Nada Alaaeddine; Baojun Xu
Journal:  Int J Mol Sci       Date:  2018-04-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.